Author + information
- Joanna Chikwe, MDa,b,∗ (, )@IcahnMountSinai@SUNY,
- Timothy Lee, MDa,
- Shinobu Itagaki, MD, MSca,
- David H. Adams, MDa and
- Natalia N. Egorova, PhDc
- aDepartment of Cardiovascular Surgery, Icahn School of Medicine at Mount Sinai, New York, New York
- bDepartment of Surgery, The State University of New York, Stony Brook, New York, New York
- cDepartment of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, New York
- ↵∗Address for correspondence:
Dr. Joanna Chikwe, Department of Cardiovascular Surgery, Icahn School of Medicine at Mount Sinai, 1190 Fifth Avenue, New York, New York 10029.
Background Long-term benefits of off-pump versus on-pump coronary artery bypass grafting (CABG) are controversial.
Objectives The authors sought to compare long-term survival and morbidity after on-pump versus off-pump CABG.
Methods Mandatory clinical and administrative registries from New Jersey Department of Health were linked to identify patients who underwent CABG between 2005 and 2011, by surgeons who had performed at least 100 off-pump or on-pump CABG operations. Survival, stroke, myocardial infarction, repeat revascularization, and new dialysis requirement were compared using Cox modeling, propensity scores, and instrumental variable analysis. Median follow-up was 6.8 years (range: 0 to 11.0 years); last follow-up date was December 31, 2015.
Results Among 42,570 CABG patients, 6,950 who underwent off-pump CABG and 15,295 who underwent on-pump CABG met study criteria. Off-pump CABG was associated with higher mortality (33.4% vs. 29.6% at 10 years; hazard ratio [HR]: 1.11; 95% confidence interval [CI]: 1.04 to 1.18; p = 0.002) compared with on-pump CABG. Off-pump CABG was associated with a higher risk of incomplete revascularization (15.7% vs. 8.8%; p < 0.001), which was a predictor of late mortality (HR: 1.10; 95% CI: 1.03 to 1.17; p = 0.006); and higher rates of repeat revascularization (15.4% vs. 14.0% at 10 years; HR: 1.17; 95% CI: 1.01 to 1.37; p = 0.048). There were no significant differences in the rate of stroke, myocardial infarction, or new dialysis.
Conclusions In this mandatory clinical registry, off-pump was associated with increased incomplete revascularization, repeat revascularization, and mortality at 10 years compared with on-pump CABG, suggesting that on-pump CABG may be the appropriate choice for most patients undergoing surgical revascularization.
The Icahn School of Medicine at Mount Sinai receives royalty payments from Edwards Lifesciences for intellectual property related to the development of 2 mitral valve repair rings, and from Medtronic for intellectual property related to the development of a tricuspid valve repair ring. Dr. Chikwe has received speaker honoraria from Edwards Lifesciences. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
- Received June 17, 2018.
- Accepted July 2, 2018.
This article requires a subscription or purchase to view the full text. If you are a subscriber or member, click Login or the Subscribe link (top menu above) to access this article.